---
title: 新冠变异株引发夏季病例激增的担忧
date: 2024-05-19T09:50:58.294Z
description: So-called FLiRT strains set to test effectiveness of vaccines against latest mutations
tags: 
- companies
author: ft
---

[原文链接](https://ft.com/content/1db295dc-a6d6-434f-af4e-ff91352b0f37)

# 新冠变异株引发夏季病例激增的担忧

新冠疫情持续了四年半，美国病例数稳步下降，接近创纪录的低点。然而，**新的新冠病毒变异株**在全球范围内传播，引发了人们对今年夏天感染病例再次激增的担忧。这种传染性极强的疾病不断**发生变异**，挑战着我们对集体免疫所取得的进展。

被称为“FLiRT”的变异毒株家族及其衍生分支正在成为主要流行毒株，其中包括KP系（尤其是 **KP.2**）和 JN.1 毒株。根据美国疾控中心的数据，FLiRT变种在美国迅速传播：仅在两个月时间里，从2023年3月到5月，**KP**.**2**变异株在全部病例中所占的比例从3.8%上升至28.2%。另一种衍生分支 KP1.1 目前占感染病例的7.6%。

虽然卫生部门正密切关注这些新进展，但他们表示目前没有证据表明随后会出现住院新冠病例激增的情况。传染病专家也持相同观点，他们预测感染数量将会增加，但并不预计医院住院率会有显著上升。然而，**问题**在于现有的 **疫苗** 对这些具有明显基因码变异的新毒株效果如何？

华威大学的病毒学家劳伦斯·杨（Lawrence Young）表示，人们依然预期加强针能够有效保护免受FLiRT导致的严重疾病影响；另一方面，范德堡大学纳什维尔分校的威廉·沙夫纳（William Schaffner）却持有不同观点。他承认实验室研究表明疫苗对这些新变种的效果有所减弱，但强调在得出有关防护水平的结论之前需要真实世界数据的支持。

FLiRT 变异株不仅仅是美国独有的现象；根据**世卫组织**的数据，在欧洲14个国家和以色列也发现了这种病毒。欧洲疾控中心报告称，目前欧洲各地的新冠活动仍然保持较低水平，但一些国家出现了轻微上升的情况。此外，JN. **1**.7 和 KP.2 这两个变异株已在欧洲大陆有少量发现。

在英国，卫生安全局报告说，几种 FLiRT 分型正以**低水平**传播，但在已测序病例中所占的比例正在增加。东英吉利大学的保罗·亨特教授（Professor Paul Hunter）解释最新数据表明住院率保持稳定，并再次强调尽管英国整体病例略有上升，但感染激增的可能性不大。

劳伦斯·杨指出，FLiRT 变异株已经在全球范围内取代了其他毒株；它已传播到加拿大、澳大利亚、泰国和印度等国。亨特教授补充说，虽然这些新变种本身可能并不更具传染性，但其优势在于对之前主导流行的毒株具有免疫优势，这可能会导致病毒在**群体免疫力减弱**的情况下进一步蔓延。

---

# New Covid Variants Stoke Fears of a Summer Surge in Cases 

**New variants** of COVID-19 are spreading globally and raising concerns about another surge in infections this summer. The highly infectious disease continues to **mutate**, challenging our progress toward collective immunity. This development comes four and a half years into the pandemic, as case numbers in the US have been steadily decreasing, nearing record lows. 

The latest variant group, dubbed "**FLiRT**", has emerged with several offshoots such as KP strains **(KP**. **2**, specifically) and JN.1 taking center stage. The **US Centers for Disease Control and Prevention (CDC)** data reveals that the FLiRT variants are rapidly spreading across the country: in just two months, from March to May 2023, the **KP.2** variant's prevalence increased from 3.8% to 28.2% of total cases. Similarly, another offshoot, KP1.1, now accounts for 7.6% of infections. 

While health authorities closely monitor these developments, they maintain that there is no evidence to suggest a subsequent surge in severe COVID-19 cases requiring hospitalization. This sentiment is echoed by infectious disease experts who foresee an increase in infections but not a dramatic rise in hospitalizations. The **question** remains how well the current **vaccines** will hold up against these new variants, especially with their distinct genetic code mutations. 

Booster shots are still expected to provide valuable protection from severe illness caused by FLiRT, according to Lawrence Young, a virologist at Warwick University. On the other hand, William Schaffner of Vanderbilt University in Nashville presents a contrasting view—while conceding that lab studies suggest some reduction in vaccine efficacy against these new variants, he emphasizes the need for real-world data before drawing conclusions about protection levels. 

The FLiRT variants are not just an American phenomenon; they have been detected in 14 European countries and Israel by the **World Health Organization (WHO)**. The **European Centre for Disease Prevention and Control** reports that COVID activity remains low across Europe, with slight increases observed in a few nations. Additionally, two of these variants **(JN. 1.7** and KP.2) have been detected in limited numbers on the continent. 

In the UK, the Health Security Agency reported that several FLiRT strains are circulating at **low levels**, but some are gaining ground as a proportion of sequenced cases. Professor Paul Hunter of the University of East Anglia interprets the latest data to suggest stable hospitalization rates and reassures that an infection surge is improbable despite slight overall case increases in the UK. 

To put things into context, Young highlights that FLiRT variants have outcompeted other strains globally—their presence has been noted in countries like Canada, Australia, Thailand, and India. Professor Hunter adds that while these new variants may not be more contagious intrinsically, their advantage lies in a slight immunity edge over previous dominant strains, which could contribute to the virus's spread within populations with **waning immunity**.

[Source Link](https://ft.com/content/1db295dc-a6d6-434f-af4e-ff91352b0f37)

